Go Pro
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel Free APH Stock Alerts

Aphria (APH) Competitors

Aphria logo
C$23.36 +0.58 (+2.55%)
As of 08/21/2026 03:58 PM Eastern
Compare

APH vs. MRV, VRX, APHA, BHC, and MJN

Should you buy Aphria stock or one of its competitors? Aphria's main competitors and comparable companies include Nuvo Pharmaceuticals (MRV), Valeant Pharmaceuticals International (VRX), Aphria (APHA), Bausch Health Companies (BHC), and Cronos Group (MJN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Aphria compare to Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals (TSE:MRV) and Aphria (TSE:APH) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

In the previous week, Nuvo Pharmaceuticals' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Nuvo Pharmaceuticals Neutral
Aphria Neutral

Aphria has higher revenue and earnings than Nuvo Pharmaceuticals. Aphria is trading at a lower price-to-earnings ratio than Nuvo Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuvo PharmaceuticalsC$8.72B3.96C$15.17MC$2.9113.23
AphriaC$29.01B0.99C$4.93BC$4.005.84

Nuvo Pharmaceuticals has a net margin of 20.95% compared to Aphria's net margin of 0.00%. Nuvo Pharmaceuticals' return on equity of 1,180.47% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
Nuvo Pharmaceuticals20.95% 1,180.47% 5.85%
Aphria N/A N/A N/A

1.8% of Nuvo Pharmaceuticals shares are held by institutional investors. Comparatively, 8.1% of Aphria shares are held by institutional investors. 6.3% of Nuvo Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Nuvo Pharmaceuticals has a beta of 0.917796, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Aphria has a beta of 3.455044, indicating that its stock price is 246% more volatile than the broader market.

Summary

Nuvo Pharmaceuticals beats Aphria on 6 of the 11 factors compared between the two stocks.

How does Aphria compare to Valeant Pharmaceuticals International?

Aphria (TSE:APH) and Valeant Pharmaceuticals International (TSE:VRX) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Valeant Pharmaceuticals International N/A N/A N/A

Aphria has higher revenue and earnings than Valeant Pharmaceuticals International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$29.01B0.99C$4.93BC$4.005.84
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A

In the previous week, Aphria's average media sentiment score of 0.00 equaled Valeant Pharmaceuticals International'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Valeant Pharmaceuticals International Neutral

8.1% of Aphria shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Aphria beats Valeant Pharmaceuticals International on 2 of the 2 factors compared between the two stocks.

How does Aphria compare to Aphria?

Aphria (TSE:APHA) and Aphria (TSE:APH) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Aphria N/A N/A N/A

Aphria has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
AphriaC$29.01B0.99C$4.93BC$4.005.84

8.1% of Aphria shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Aphria's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Aphria Neutral

Summary

Aphria beats Aphria on 5 of the 5 factors compared between the two stocks.

How does Aphria compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Aphria (TSE:APH) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

In the previous week, Bausch Health Companies had 14 more articles in the media than Aphria. MarketBeat recorded 14 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 0.49 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company Overall Sentiment
Bausch Health Companies Neutral
Aphria Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aphria has higher revenue and earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.85B0.30-C$125.65M-C$2.94N/A
AphriaC$29.01B0.99C$4.93BC$4.005.84

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-12.02% 87.57% 4.16%
Aphria N/A N/A N/A

Bausch Health Companies has a beta of 0.959729, meaning that its stock price is 4% less volatile than the broader market. Comparatively, Aphria has a beta of 3.455044, meaning that its stock price is 246% more volatile than the broader market.

10.4% of Bausch Health Companies shares are held by institutional investors. Comparatively, 8.1% of Aphria shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Bausch Health Companies and Aphria tied by winning 7 of the 14 factors compared between the two stocks.

How does Aphria compare to Cronos Group?

Cronos Group (CVE:MJN) and Aphria (TSE:APH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Cronos Group pays an annual dividend of C$1.65 per share and has a dividend yield of 13.6%. Aphria pays an annual dividend of C$0.03 per share and has a dividend yield of 0.1%. Aphria pays out 0.7% of its earnings in the form of a dividend.

Aphria has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupN/AN/AN/AN/AN/A
AphriaC$29.01B0.99C$4.93BC$4.005.84

Company Net Margins Return on Equity Return on Assets
Cronos GroupN/A N/A N/A
Aphria N/A N/A N/A

8.1% of Aphria shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Cronos Group had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Aphria. Cronos Group's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Cronos Group Neutral
Aphria Neutral

Summary

Cronos Group beats Aphria on 3 of the 5 factors compared between the two stocks.

Get Aphria News Delivered to You Automatically

Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APH vs. The Competition

Export
MetricAphriaPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$28.80BC$12.57BC$7.37BC$12.56B
Dividend Yield0.15%2.61%2.53%6.21%
P/E Ratio5.84789.80272.6039.07
Price / Sales0.99764.50618.9610.02
Price / CashN/A96.7778.6282.29
Price / BookN/A11.8913.054.79
Net IncomeC$4.93BC$2.81BC$3.47BC$299.09M
7 Day Performance-6.11%1.77%2.09%0.82%
1 Month Performance-0.43%3.85%6.64%5.39%
1 Year PerformanceN/A6.56%25.02%35.05%

Aphria Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APH
Aphria
N/AC$23.36
+2.5%		N/AN/AC$28.80BC$29.01B5.8480,000
MRV
Nuvo Pharmaceuticals
N/AC$38.45
-5.4%		N/AN/AC$34.51BC$8.72B13.21N/A
VRX
Valeant Pharmaceuticals International
N/AN/AN/AN/AC$10.76BN/AN/AN/A
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06MN/A1,200
BHC
Bausch Health Companies
0.9375 of 5 stars		C$8.95
-4.9%		N/A-15.0%C$3.35BC$10.85BN/A19,900

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:APH) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel